ArticleNature metabolism2023
Vitamin B
Open access · hybridAbstract read
In one paragraph
Article in Nature metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 55 citations in OpenAlex.
- Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026Review
- Vitamin B5 supports anti-PD1 response in HER2-positive gastric cancer and enhances interaction between naïve B cells and T cells.Nature communications · 2026Article
- Structural basis for multivitamin recognition and transport by human SMVT.Nature communications · 2026Article
- When vitamins decide life or death.Cell death and differentiation · 2026Article
- A liquid chromatography-mass spectrometry method to quantify total Coenzyme A concentration and isotopic labeling.bioRxiv : the preprint server for biology · 2026Article
- Inflammation and Colorectal Cancer Pathogenesis: Molecular, Immunological, and Environmental Features for Therapy Response and Resistances.International journal of molecular sciences · 2026Review
- Decoding cancer across scales with metabolomics.Nature reviews. Cancer · 2026Review
- The advent of precision nutrigeroscience in cancer: from clinic towards molecular biology.Journal of advanced research · 2026Review
- Renal coenzyme A (CoA) production from VB5 fuels stem cell proliferation and tumor growth.Nature communications · 2026Article
- Mitophagy-driven multidimensional regulation of tumor immune evasion and context-dependent therapeutic strategies.Journal of translational medicine · 2026Review
- Metabolic reprogramming in cancer: signaling pathways and therapeutic targets.Molecular cancer · 2026Review
- A novel prognostic model for colon adenocarcinoma based on cofactor and vitamin metabolism-related genes.Translational cancer research · 2026Article
- Spatially resolved integrative analysis of transcriptomic and metabolomic changes in tissue injury studies.Nature communications · 2026Article
- Bone marrow stromal cells enhance multiple myeloma cells proliferation through regulating LncRNA OVAAL/ENPP1 axis.Open life sciences · 2026Article
- Tumor metabolic plasticity in therapy resistance: from the Warburg effect to mitochondrial hijacking.Theranostics · 2026Review
- Breast cancer pathogenesis, diagnosis and treatment: a comprehensive review.Frontiers in oncology · 2026Review
- Dietary methionine deprivation enhances renal resilience against ischemia-reperfusion injury in mice through modulation of glucose oxidation.Communications biology · 2025Article
- Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var.Nature communications · 2025Article
- Multifaceted role of the vitamin B6 pathway in cancer: metabolism, immune interaction, and temporal and spatial regulation.Genes & development · 2025Review
- Progress in monitoring molecular, cellular and metabolic dynamics using mass spectrometry imaging.Bioanalysis · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors at 6 institutions in 3 countries.
Peter KreuzalerThe Francis Crick Institute, London, UK. peter.kreuzaler@uni-koeln.de.ORCID 0000-0001-8684-9424
Paolo Inglese *Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, South Kensington Campus, London, UK.ORCID 0000-0001-6179-9643
Avinash Ghanate *The Francis Crick Institute, London, UK.ORCID 0000-0002-6284-7667
Ersa Gjelaj *The Francis Crick Institute, London, UK.ORCID 0000-0002-5168-3724
Vincen WuFaculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, South Kensington Campus, London, UK.
Yulia PaninaThe Francis Crick Institute, London, UK.
Andres Mendez-LucasThe Francis Crick Institute, London, UK.
Catherine MacLachlanThe Francis Crick Institute, London, UK.ORCID 0000-0002-3606-6672
Neill PataniThe Francis Crick Institute, London, UK.
Catherine B HubertThe Francis Crick Institute, London, UK.ORCID 0000-0001-6057-8734
Helen HuangFaculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, South Kensington Campus, London, UK.
Gina GreenidgeThe National Physical Laboratory, Teddington, UK.
Oscar M RuedaUniversity of Cambridge, MRC Biostatistics Unit, Cambridge Biomedical Campus, Cambridge, UK.ORCID 0000-0003-0008-4884
Adam J TaylorThe National Physical Laboratory, Teddington, UK.
Evdoxia KaraliSignalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.ORCID 0000-0002-1196-3553
Emine KazancSignalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.
Amy SpicerThe Francis Crick Institute, London, UK.ORCID 0000-0001-6474-1498
Alex DexterThe National Physical Laboratory, Teddington, UK.ORCID 0000-0001-8536-4417
Wei LinThe Francis Crick Institute, London, UK.
Daria ThompsonThe Francis Crick Institute, London, UK.
Mariana Silva Dos SantosThe Francis Crick Institute, London, UK.ORCID 0000-0003-2404-8490
Enrica CalvaniThe Francis Crick Institute, London, UK.
Nathalie LegraveThe Francis Crick Institute, London, UK.ORCID 0000-0003-1172-4955
James K EllisThe Francis Crick Institute, London, UK.
Wendy GreenwoodUniversity of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.ORCID 0000-0002-2509-8695
Mary GreenThe Francis Crick Institute, London, UK.
Emma NyeThe Francis Crick Institute, London, UK.
Emma StillThe Francis Crick Institute, London, UK.
CRUK Rosetta Grand Challenge Consortium
Simon BarryImaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.ORCID 0000-0002-8511-0588
Richard J A GoodwinImaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.ORCID 0000-0001-5699-8488
Alejandra BrunaModelling of Paediatric Cancer Evolution, Centre for Paediatric Oncology, Experimental Medicine, Centre for Cancer Evolution: Molecular Pathology Division, The Institute of Cancer Research, Belmont, Sutton, London, UK.ORCID 0000-0003-1214-9665
Carlos CaldasUniversity of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.ORCID 0000-0003-3547-1489
James MacRaeThe Francis Crick Institute, London, UK.ORCID 0000-0002-1464-8583
Luiz Pedro Sório de CarvalhoThe Francis Crick Institute, London, UK.
George PoulogiannisSignalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.ORCID 0000-0002-0529-8614
Greg McMahonThe National Physical Laboratory, Teddington, UK.
Zoltan TakatsFaculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, South Kensington Campus, London, UK.ORCID 0000-0002-0795-3467
Josephine BunchThe National Physical Laboratory, Teddington, UK.
Mariia YunevaThe Francis Crick Institute, London, UK. Mariia.Yuneva@crick.ac.uk.ORCID 0000-0003-3455-9374
The Francis Crick Institute · GBNational Physical Laboratory · GBImperial College London · GBInstitute of Cancer Research · GBUniversity of Cambridge · GBAstraZeneca (United Kingdom) · GB
Funding
Medical Research Council MC_UU_00002/16Wellcome Trust FC001223
Abstract
Tumors are intrinsically heterogeneous and it is well established that this directs their evolution, hinders their classification and frustrates therapy
Indexed as
Breast NeoplasmsAnimalsFemaleHumansMicePantothenic AcidProto-Oncogene Proteins c-mycTranscription FactorsVitaminsPantothenic AcidProto-Oncogene Proteins c-mycTranscription FactorsVitamins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.